Rated well-being in relation to plasma concentrations of l- and d- methadone in satisfied and dissatisfied patients on methadone maintenance treatment

Psychopharmacology

Volumn 143, Issue 4, 1999, Pages 385-393

  Hiltunen, A J ^a,b   Beck, O ^b   Hjemdahl, P ^b   Liljeberg, P ^a   Almstrom U ^a   Brodin, K ^b   Von Wachenfeldt, J ^a   Borg, S ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Abused drug; Chiral analysis; Daily variation; Dose adjustment; Human; Methadone; Methadone maintenance treatment; Plasma; Rating scales; Urine

Indexed keywords

METHADONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG DEPENDENCE TREATMENT; ENANTIOMER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METHADONE TREATMENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; RATING SCALE; WELLBEING;

ADULT; ANALYSIS OF VARIANCE; FEMALE; HALF-LIFE; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; MIDDLE AGED; PATIENT SATISFACTION; REGRESSION ANALYSIS; STEREOISOMERISM; STREET DRUGS;

EID: 0032947543     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050963     Document Type: Article

References (29)

1. Änggård E, Gunne LM, Holmstrand J, McMahon RE, Sandberg CG, Sullivan HR (1975) Disposition of methadone in methadone maintenance. Clin Pharmacol Ther 17: 258-266
2. Beck O, Boreus L, Borg S, Jacobsson G, Lafolie P, Stensiö M (1990) Monitoring of plasma methadone: intercorrelation between immunoassay and gas chromatography-mass spectrometry. Ther Drug Monit 12: 473-477
3. Beck O, Boreus LO, Lafolie P, Jacobsson G (1991) Chiral high performance liquid chromatographic analysis of methadone in patient plasma. J Chromatogr Biomed Appl 570: 198-202
4. Bell J, Seres V, Bowron P, Lewis J, Batey R (1988) The use of serum methadone levels in patients receiving methadone maintenance. Clin Pharmcol Ther 43: 623-629
5. Dole VP (1988) Implications of methadone maintenance for theories of narcotic addiction. JAMA 260: 3025-3029
6. Eap CB, Finkbeiner T, Gastpar M, Scherbaum N, Powell K, Baumann P (1996) Replacement of (R)-methadone by a double dose of (R, S)-methadone in addicts: interindividual variability of the (R)/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics. Eur J Clin Pharmacol 50: 385-389
7. Edwards AL (1979) Multiple regression and the analysis of variance and co-variance. Freeman, New York
8. Handelsman L, Cochrane KJ, Aronson MJ, Ness R, Rubinstein KJ, Kanof PD (1987) Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 13: 293-308
9. Hiltunen AJ, Lafolie P, Martel J, Ottosson E-C, Boreus LO, Beck O, Borg S, Hjemdahl P (1995) Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients. Psychopharmacology 118: 122-126
10. Holmstrand J, Änggård E, Gunne LM (1978) Methadone maintenance: plasma levels and therapeutic outcome. Clin Pharmacol Ther 23: 175-180
11. Iribarne C, Berthou F, Baird S, Dreano Y, Picart D, Bail JP, Beaune P, Menez JF (1996) Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chem Res Toxicol 9: 365-373
12. Isbell H, Eisenman AJ (1948) The addiction liability of some drug of the methadone series. J Pharmacol Exp Ther 93: 305-313
13. Judson BA, Horns WH, Goldstein A (1976) Side effects of levomethadone and racemic methadone in a maintenance program. Clin Pharmacol Ther 20: 445-449
14. Kell M (1994) Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics: I. Measurement techniques for a clinical setting. J Addict Dis 13: 5-26
15. Kell MJ (1995) Utilization of plasma and urine methadone concentration measurements to limit narcotics use in methadone maintenance patients. 2. Generation of plasma concentration response curves. J Addict Dis 14: 85-108
16. Kirk RE (1969) Experimental design: Procedures for the behavioral sciences. Brooks/Cole, Monterey, Calif.
17. Kreek MJ (1973) Plasma and urine levels of methadone. NY State J Med 73: 2773-2777
18. Kreek MJ, Hachey DL, Klein PD (1979) Stereoselective disposition of methadone in man. Life Sci 24: 925-932
19. 2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci 56: 45-50
20. Loimer N, Schmid R, Grunberger J, Jagsch R, Linzmayer L, Presslich O (1991) Psychophysiological reactions in methadone maintenance patients do not correlate with methadone plasma levels. Psychopharmacology 103: 538-540
21. Moody DE, Alburges ME, Parker RJ, Collins JM, Strong JM (1997) The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLaam, and methadone. Drug Metab Dispos 25: 1347-1353
22. Scherbaum N, Finkbeiner T, Leifert K, Gastpar M (1996) The efficacy of l-methadone and racemic methadone in substitution treatment for opiate addicts - a double-blind comparison. Pharmacopsychiatry 29: 212-215
23. Scott CC, Robbins EB, Chen KK (1948) Pharmacologic comparison of the optical isomers of methadon. J Pharmacol Exp Ther 93: 282-286
24. Shimoyama N, Shimoyama M, Elliott KJ, Inturrisi CE (1997) d-Methadone is antinociceptive in the rat formalin test. J Pharmacol Exp Ther 283: 648-652
25. Tennant FS Jr (1987) Inadequate plasma concentrations in some high-dose methadone maintenance patients. Am J Psychiatry 144: 1349-1350
26. Tennant F, Shannon J (1995) Cocaine abuse in methadone maintenance patients is associated with low serum methadone concentrations. J Addict Dis 14: 67-74
27. Wolff K, Hay A, Raistrick D, Calvert R, Feely M (1991a) Measuring compliance in methadone maintenance patients: use of a pharmacologic indicator to "estimate" methadone plasma levels. Clin Pharmacol Ther 50: 199-207
28. Wolff K, Sanderson M, Hay AWM, Raistrick D (1991b) Methadone concentrations in plasma and their relationship to drug dosage. Clin Chem 37: 205-209
29. Wolff K, Hay AW, Raistrick D (1992) Plasma methadone measurements and their role in methadone detoxification programs. Clin Chem 38: 420-425